1. Home
  2. INBK vs SLGL Comparison

INBK vs SLGL Comparison

Compare INBK & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Internet Bancorp

INBK

First Internet Bancorp

N/A

Current Price

$28.41

Market Cap

255.0M

Sector

Finance

ML Signal

N/A

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

N/A

Current Price

$76.32

Market Cap

254.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INBK
SLGL
Founded
1999
1997
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
255.0M
254.1M
IPO Year
2013
2016

Fundamental Metrics

Financial Performance
Metric
INBK
SLGL
Price
$28.41
$76.32
Analyst Decision
Hold
Strong Buy
Analyst Count
2
1
Target Price
$23.25
$110.00
AVG Volume (30 Days)
39.0K
42.4K
Earning Date
04-30-2026
05-22-2026
Dividend Yield
1.06%
N/A
EPS Growth
N/A
N/A
EPS
0.55
N/A
Revenue
$11,541,000.00
N/A
Revenue This Year
$279.34
N/A
Revenue Next Year
$12.97
$223.84
P/E Ratio
$53.09
N/A
Revenue Growth
101.84
N/A
52 Week Low
$17.05
$20.10
52 Week High
$31.09
$97.97

Technical Indicators

Market Signals
Indicator
INBK
SLGL
Relative Strength Index (RSI) 55.16 45.94
Support Level $25.23 $67.89
Resistance Level $29.98 $81.18
Average True Range (ATR) 0.80 6.36
MACD -0.11 -0.89
Stochastic Oscillator 44.33 33.93

Price Performance

Historical Comparison
INBK
SLGL

About INBK First Internet Bancorp

First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.

Share on Social Networks: